Soluble CD30 and Hepatocyte growth factor as predictive markers of antibody-mediated rejection of the kidney allograft
Our retrospective study was aimed to assess the relevance of pre- and post-transplant measurements of serum concentrations of the soluble CD30 molecule (soluble CD30, sCD30) and the cytokine Hepatocyte growth factor (HGF) for prediction of the risk for development of antibody-mediated rejection (AMR...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
3 March 2011
|
| In: |
Transplant immunology
Year: 2011, Jahrgang: 25, Heft: 1, Pages: 72-76 |
| ISSN: | 1878-5492 |
| DOI: | 10.1016/j.trim.2011.02.003 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.trim.2011.02.003
|
| Verfasserangaben: | Yelena Pavlova, Ondrej Viklicky, Janka Slatinska, Marcela Bürgelova, Caner Süsal, Jelena Skibova, Eva Honsová, Ilja Striz, Libor Kolesar, Antonij Slavcev |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1818149516 | ||
| 003 | DE-627 | ||
| 005 | 20230710112238.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 221006s2011 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.trim.2011.02.003 |2 doi | |
| 035 | |a (DE-627)1818149516 | ||
| 035 | |a (DE-599)KXP1818149516 | ||
| 035 | |a (OCoLC)1389779414 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Pavlova, Yelena |e VerfasserIn |0 (DE-588)1269637169 |0 (DE-627)1818150700 |4 aut | |
| 245 | 1 | 0 | |a Soluble CD30 and Hepatocyte growth factor as predictive markers of antibody-mediated rejection of the kidney allograft |c Yelena Pavlova, Ondrej Viklicky, Janka Slatinska, Marcela Bürgelova, Caner Süsal, Jelena Skibova, Eva Honsová, Ilja Striz, Libor Kolesar, Antonij Slavcev |
| 264 | 1 | |c 3 March 2011 | |
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 06.10.2022 | ||
| 520 | |a Our retrospective study was aimed to assess the relevance of pre- and post-transplant measurements of serum concentrations of the soluble CD30 molecule (soluble CD30, sCD30) and the cytokine Hepatocyte growth factor (HGF) for prediction of the risk for development of antibody-mediated rejection (AMR) in kidney transplant patients. Evaluation of sCD30, HGF levels and the presence of HLA-specific antibodies in a cohort of 205 patients was performed before, 2weeks and 6months after transplantation. Patients were followed up for kidney graft function and survival for two years. We found a tendency of higher incidence of AMR in retransplanted patients with elevated pre-transplant sCD30 (≥100U/ml) (p=0.051), however no such correlation was observed in first-transplant patients. Kidney recipients with simultaneously high sCD30 and HLA-specific antibodies (sCD30+/Ab+) before transplantation had significantly lower AMR-free survival compared to the other patient groups (p<0.001). HGF concentrations were not associated with the incidence of AMR at any time point of measurement, nevertheless, the combined analysis HGF and sCD30 showed increased incidence of AMR in recipients with elevated pretransplant sCD30 and low HGF levels. - CONCLUSION: the predictive value of pretransplant sCD30 for the development of antibody-mediated rejection after transplantation is significantly potentiated by the co-presence of HLA specific antibodies. The role of HGF as a rejection-protective factor in patients with high pretransplant HGF levels would need further investigation. | ||
| 650 | 4 | |a Aged | |
| 650 | 4 | |a Antibody Formation | |
| 650 | 4 | |a Biomarkers | |
| 650 | 4 | |a Female | |
| 650 | 4 | |a Graft Rejection | |
| 650 | 4 | |a Hepatocyte Growth Factor | |
| 650 | 4 | |a HLA Antigens | |
| 650 | 4 | |a Humans | |
| 650 | 4 | |a Isoantibodies | |
| 650 | 4 | |a Ki-1 Antigen | |
| 650 | 4 | |a Kidney Transplantation | |
| 650 | 4 | |a Male | |
| 650 | 4 | |a Middle Aged | |
| 650 | 4 | |a Retrospective Studies | |
| 650 | 4 | |a Survival Rate | |
| 650 | 4 | |a Time Factors | |
| 650 | 4 | |a Transplantation, Homologous | |
| 700 | 1 | |a Viklicky, Ondrej |e VerfasserIn |4 aut | |
| 700 | 1 | |a Slatinska, Janka |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bürgelova, Marcela |e VerfasserIn |4 aut | |
| 700 | 1 | |a Süsal, Caner |e VerfasserIn |0 (DE-588)102648037X |0 (DE-627)726772763 |0 (DE-576)37182673X |4 aut | |
| 700 | 1 | |a Skibova, Jelena |e VerfasserIn |4 aut | |
| 700 | 1 | |a Honsová, Eva |e VerfasserIn |4 aut | |
| 700 | 1 | |a Striz, Ilja |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kolesar, Libor |e VerfasserIn |4 aut | |
| 700 | 1 | |a Slavcev, Antonij |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Transplant immunology |d Amsterdam [u.a.] : Elsevier, 1993 |g 25(2011), 1, Seite 72-76 |h Online-Ressource |w (DE-627)324489110 |w (DE-600)2027651-5 |w (DE-576)26442414X |x 1878-5492 |7 nnas |a Soluble CD30 and Hepatocyte growth factor as predictive markers of antibody-mediated rejection of the kidney allograft |
| 773 | 1 | 8 | |g volume:25 |g year:2011 |g number:1 |g pages:72-76 |g extent:5 |a Soluble CD30 and Hepatocyte growth factor as predictive markers of antibody-mediated rejection of the kidney allograft |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.trim.2011.02.003 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20221006 | ||
| 993 | |a Article | ||
| 994 | |a 2011 | ||
| 998 | |g 102648037X |a Süsal, Caner |m 102648037X:Süsal, Caner |d 910000 |d 911600 |d 50000 |e 910000PS102648037X |e 911600PS102648037X |e 50000PS102648037X |k 0/910000/ |k 1/910000/911600/ |k 0/50000/ |p 5 | ||
| 999 | |a KXP-PPN1818149516 |e 4194834828 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"role":"aut","display":"Pavlova, Yelena","roleDisplay":"VerfasserIn","given":"Yelena","family":"Pavlova"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Viklicky, Ondrej","given":"Ondrej","family":"Viklicky"},{"role":"aut","display":"Slatinska, Janka","roleDisplay":"VerfasserIn","given":"Janka","family":"Slatinska"},{"display":"Bürgelova, Marcela","roleDisplay":"VerfasserIn","role":"aut","family":"Bürgelova","given":"Marcela"},{"role":"aut","display":"Süsal, Caner","roleDisplay":"VerfasserIn","given":"Caner","family":"Süsal"},{"given":"Jelena","family":"Skibova","role":"aut","display":"Skibova, Jelena","roleDisplay":"VerfasserIn"},{"given":"Eva","family":"Honsová","role":"aut","roleDisplay":"VerfasserIn","display":"Honsová, Eva"},{"roleDisplay":"VerfasserIn","display":"Striz, Ilja","role":"aut","family":"Striz","given":"Ilja"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Kolesar, Libor","given":"Libor","family":"Kolesar"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Slavcev, Antonij","given":"Antonij","family":"Slavcev"}],"title":[{"title":"Soluble CD30 and Hepatocyte growth factor as predictive markers of antibody-mediated rejection of the kidney allograft","title_sort":"Soluble CD30 and Hepatocyte growth factor as predictive markers of antibody-mediated rejection of the kidney allograft"}],"note":["Gesehen am 06.10.2022"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1818149516","language":["eng"],"name":{"displayForm":["Yelena Pavlova, Ondrej Viklicky, Janka Slatinska, Marcela Bürgelova, Caner Süsal, Jelena Skibova, Eva Honsová, Ilja Striz, Libor Kolesar, Antonij Slavcev"]},"origin":[{"dateIssuedDisp":"3 March 2011","dateIssuedKey":"2011"}],"id":{"eki":["1818149516"],"doi":["10.1016/j.trim.2011.02.003"]},"physDesc":[{"extent":"5 S."}],"relHost":[{"origin":[{"publisherPlace":"Amsterdam [u.a.]","dateIssuedDisp":"1993-","dateIssuedKey":"1993","publisher":"Elsevier"}],"id":{"eki":["324489110"],"zdb":["2027651-5"],"issn":["1878-5492"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Transplant immunology","title_sort":"Transplant immunology"}],"note":["Gesehen am 30.08.04"],"disp":"Soluble CD30 and Hepatocyte growth factor as predictive markers of antibody-mediated rejection of the kidney allograftTransplant immunology","type":{"bibl":"periodical","media":"Online-Ressource"},"recId":"324489110","language":["eng"],"pubHistory":["1.1993 -"],"part":{"extent":"5","text":"25(2011), 1, Seite 72-76","volume":"25","issue":"1","pages":"72-76","year":"2011"}}]} | ||
| SRT | |a PAVLOVAYELSOLUBLECD33201 | ||